Literature DB >> 3155493

Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin papillomas and carcinomas by dehydroepiandrosterone and 3-beta-methylandrost-5-en-17-one in mice.

L L Pashko, G C Hard, R J Rovito, J R Williams, E L Sobel, A G Schwartz.   

Abstract

Topical application of the adrenal steroid, dehydroepiandrosterone, or the synthetic steroid, 3-beta-methylandrost-5-en-17-one, which unlike dehydroepiandrosterone is not demonstrably uterotrophic, inhibits 7,12-dimethylbenz(a)anthracene-induced skin papillomas and carcinomas in the CD-1 mouse.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3155493

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  3 in total

Review 1.  Does G6PD deficiency protect against cancer? A critical review.

Authors:  P Cocco
Journal:  J Epidemiol Community Health       Date:  1987-06       Impact factor: 3.710

Review 2.  The effects of dehydroepiandrosterone on carcinogenesis, obesity, the immune system, and aging.

Authors:  J R Williams
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

3.  Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells.

Authors:  M Di Monaco; A Pizzini; V Gatto; L Leonardi; M Gallo; E Brignardello; G Boccuzzi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.